You just read:

PROLOR Biotech Announces Positive Top-Line Results From Phase II Trial of its Long-Acting Human Growth Hormone That Achieved All Key Study Goals

News provided by

PROLOR Biotech, Inc.

Aug 04, 2011, 06:00 ET